Vaccine innovation to prevent disease

about vaxxilon

At Vaxxilon, our goal is to discover and develop innovative vaccines to prevent disease. Our corporate values, employees, and partners are essential to improving health and building a great company.

Vaxxilon Shares Transferred to Idorsia as part of the J&J Actelion Acquisition
June 16, 2017

Actelion Ltd was the principal investor and majority shareholder of Vaxxilon AG since its inception in June 2015.

VPM – 10th International VPM Days
TWINCORE in Hannover, Germany | September 14, 2017

10th International VPM Days “15 Years VPM – from Target to Market” to be held on September 14 – 15, 2017 at the TWINCORE in Hannover, Germany

Basel Area Vaxxilon AG Christoph Merian-Ring 11, 4153 Reinach, Switzerland

Berlin Area (Adlershof) Vaxxilon Deutschland GmbH Magnusstraße 11, 12489 Berlin, Germany